Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation

被引：9
|
作者：
Mohty, Mohamad [1 ]
Malard, Florent
机构：
[1] Hop St Antoine, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 36期
关键词：
MATCHED UNRELATED DONORS; ANTI-THYMOCYTE GLOBULIN; OPEN-LABEL; HEMATOLOGICAL MALIGNANCIES; PHASE-3; TRIAL; MULTICENTER; MARROW; PREVENTION; MORTALITY; OUTCOMES;
D O I：
10.1200/JCO.2017.76.0512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3993 / +
页数：4
相关论文
共 50 条
  • [31] Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Sun, Huimin
    Wu, Linjie
    Zhao, Xueying
    Huo, Yingying
    Dong, Peiyuan
    Pang, Aiming
    Zheng, Yawei
    Han, Yiwen
    Ma, Shihui
    Jiang, Erlie
    Dong, Fang
    Cheng, Tao
    Hao, Sha
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [32] Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation
    Lertkovit, Oranooj
    Anurathapan, Usanarat
    Hongeng, Suradej
    Thokanit, Nintita Sripaiboonkit
    Pakakasama, Samart
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (04) : 556 - 565
  • [33] Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Grau, Santiago
    Camara, Rafael
    Jurado, Manuel
    Sanz, Jaime
    Aragon, Belen
    Gozalbo, Irmina
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (04): : 627 - 636
  • [34] Microparticles for Diagnosis of Graft-Versus-Host Disease After Allogeneic Stem Transplantation
    Rank, Andreas
    Nieuwland, Rienk
    Toth, Bettina
    Pihusch, Verena
    Delker, Ruth
    Hiller, Erhard
    Kolb, Hans-Jochem
    Pihusch, Rudolf
    TRANSPLANTATION, 2011, 92 (02) : 244 - 250
  • [35] Model-Based Antithymocyte Globulin in αβhaplo-Hematopoietic Stem Cell Transplantation Facilitates Engraftment, Expedites T Cell Recovery, and Mitigates the Risk of Acute Graft-versus-Host Disease
    Barbarito, Giulia
    Hiroshima, Lyndsie
    Oppizzi, Linda
    Saini, Gopin
    Kristovich, Karen
    Klein, Orly
    Hosszu, Kinga
    Boehlke, Kylan
    Gupta, Aditi
    Mcavoy, Devin
    Shyr, David
    Boelens, Jaap Jan
    Bertaina, Alice
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (08): : 810e1 - 810e16
  • [36] Successful Prevention of Acute Graft-versus-Host Disease Using Low-Dose Antithymocyte Globulin after Mismatched, Unrelated, Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia
    Kim, Hee-Je
    Min, Woo-Sung
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Min, Chang-Ki
    Lee, Seok
    Cho, Seok-Goo
    Jin, Jong-Youl
    Lee, Jong-Wook
    Kim, Chun-Choo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (06) : 704 - 717
  • [37] Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation
    Chalchal, Hafsah
    Dhir, Vinita
    Masurekar, Ashish
    Atkins, Harold
    Bredeson, Christopher
    Kennah, Michael
    Kekre, Natasha
    Allan, David
    Nampoothiri, Ram Vasudevan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 543 - 549
  • [38] Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
    Salas, Maria Queralt
    Alfaro-Moya, Tommy
    Atenafu, Eshetu G.
    Law, Arjun Datt
    Lam, Wilson
    Pasic, Ivan
    Novitzky-Basso, Igor
    Carreira, Abel Santos
    Chen, Carol
    V. Michelis, Fotios
    Gerbitz, Armin
    Lipton, Jeffrey Howard
    Kim, Dennis
    Kumar, Rajat
    Mattsson, Jonas
    Viswabandya, Auro
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (05): : 536.e1 - 536.e13
  • [39] PHARMACOLOGICAL PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    SCHWINGHAMMER, TL
    BLOOM, EJ
    CLINICAL PHARMACY, 1993, 12 (10): : 736 - 761
  • [40] Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
    Rashid, Nahid
    Gooley, Ted
    Furlong, Terry
    Lee, Stephanie J.
    Martin, Paul J.
    Storb, Rainer
    Mielcarek, Marco
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 701.e1 - 701.e8
12345